Trials / Terminated
TerminatedNCT05058014
Skeletal Metastasis Registry
The International Skeletal Metastasis Registry
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Academic / Other
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, observational study designed to contribute data from patients with symptomatic metastatic bone disease treated at Sibley Memorial Hospital and Johns Hopkins Medicine to an international registry hosted by the Swedish Regional Cancer Centrum in Stockholm, Sweden. This protocol supports a worldwide effort to collect and store information from patients treated for symptomatic bone metastases within the International Skeletal Metastasis Registry (ISMR)
Detailed description
The registry is designed to update a suite of clinical decision-support tools designed for use when treating patients with metastatic bone disease. The models estimate the likelihood of survival at 1, 3, 6, 12, 18, and 24 months post surgery, which in turn, may be used for surgical decision-making.
Conditions
Timeline
- Start date
- 2018-08-16
- Primary completion
- 2023-12-06
- Completion
- 2023-12-06
- First posted
- 2021-09-27
- Last updated
- 2024-10-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05058014. Inclusion in this directory is not an endorsement.